DUSP6 overexpression in HER2+ breast cancer was confirmed in the TCGA breast invasive carcinoma dataset (Dataref: Cerami et al, 2012; de Bruijn et al, 2023; Gao et al, 2013) (Appendix Fig. S2B). Here, ERBB2 is linked to breast carcinoma.